Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 09, 2016 ) DelveInsight's, " Pertussis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Pertussis. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Pertussis. DelveInsight's Report also assesses the Pertussis therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.
For more information http://www.reportsweb.com/pertussis-pipeline-insights-2016
Table of Contents
- Pertussis Overview - Pertussis Pipeline Therapeutics - Pertussis Therapeutics under Development by Companies - Pertussis Filed and Phase III Products - Comparative Analysis - Pertussis Phase II Products - Comparative Analysis - Pertussis Phase I and IND Filed Products - Comparative Analysis - Pertussis Discovery and Pre-Clinical Stage Products - Comparative Analysis - Drug Candidate Profiles - Pertussis - Therapeutics Assessment - Assessment by Monotherapy Products - Assessment by Combination Products - Assessment by Route of Administration - Assessment by Molecule Type - Pertussis - Discontinued Products - Pertussis - Dormant Products - Companies Involved in Therapeutics Development for Pertussis - Appendix - Methodology - Contact Us - Disclaimer
Request Sample Copy http://www.reportsweb.com/inquiry&RW000183418/sample
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|